These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6169610)

  • 1. [Use of trasylol as an inhibitor of proteases of the fibrinolysis system during extracorporeal circulation].
    Masiak M; Bross W
    Folia Med Cracov; 1980; 22(3-4):455-61. PubMed ID: 6169610
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolysis and loss of blood following prostatic surgery and their susceptibility to antifibrinolyties. Epsilon aminocaproic acid and the kallikrein inhibitor trasylol].
    Schmutzler R; Fürstenberg H
    Dtsch Med Wochenschr; 1966 Feb; 91(7):297-303. PubMed ID: 5295336
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mode of action of proteinase inhibitors (Trasylol) in intracranial hemorrhages].
    Koos W; Kraus H; Blümel G; Böck F
    Neurochirurgie; 1970 Nov; 16(6):548-50. PubMed ID: 5312883
    [No Abstract]   [Full Text] [Related]  

  • 4. Protease inhibitors in the treatment of hereditary angioedema.
    Ritchie BC
    Transfus Apher Sci; 2003 Dec; 29(3):259-67. PubMed ID: 14572819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protease inhibitors and antifibrinolytic therapy].
    Manrique R
    Arq Bras Cardiol; 1984 Nov; 43(5):355-60. PubMed ID: 6242229
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological properties of aprotinin and its therapeutic use in heart surgery].
    Carrera A; Fernández P; García del Valle S; de la Quintana B; Martínez MV
    Rev Esp Anestesiol Reanim; 1993; 40(5):292-9. PubMed ID: 7504313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antifibrinolytic agents and extracorporeal circulation].
    Gomes OM; Freitas Neto AG; Wolosker M; Langer B; Dubieu WK; Zerbini EJ
    Rev Hosp Clin Fac Med Sao Paulo; 1972; 27(5):209-13. PubMed ID: 4538812
    [No Abstract]   [Full Text] [Related]  

  • 8. [The blood cogulation and fibrinolytic enzyme system during and after extracorporeal circulation].
    Goldschmidt B; Böröcz L; Haas M; Büky B
    Orv Hetil; 1970 May; 111(18):1027-30. PubMed ID: 5454001
    [No Abstract]   [Full Text] [Related]  

  • 9. [Substances inhibiting fibrinolysis].
    Lakin KM; Rachitskaia NG; Gavrilov AP
    Kardiologiia; 1972 Apr; 12(4):139-53. PubMed ID: 4558033
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intraportal inhibition of proteinase by Trasylol after prolonged perfusion].
    Holec V; Siska K; Hoja S; Ziegelhöffer A; Gabauer I; Styk J; Sventeková A; Pancza D
    Rozhl Chir; 1972 Oct; 51(10):613-20. PubMed ID: 4538929
    [No Abstract]   [Full Text] [Related]  

  • 11. [The level of plasmakininogen and proteinase inhibitors; studies during the substitution therapy in hemophilia A].
    Blümel G; Fischer M; Lechner K
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):364-74. PubMed ID: 5301666
    [No Abstract]   [Full Text] [Related]  

  • 12. High dose aprotinin reduces prothrombin and fibrinogen conversion in patients undergoing extracorporeal circulation for myocardial revascularization.
    Spannagl M; Dietrich W; Beck A; Schramm W
    Thromb Haemost; 1994 Jul; 72(1):159-60. PubMed ID: 7526484
    [No Abstract]   [Full Text] [Related]  

  • 13. [Low doses of aprotinin in reducing blood loss and allogenic transfusions in operation under conditions of extracorporeal circulation with using cell saver].
    Naumenko SE; Naumenko KS; Pokrovskiĭ MG
    Vestn Khir Im I I Grek; 2005; 164(6):69-73. PubMed ID: 16792320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
    Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CU-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties.
    Dietrich W; Nicklisch S; Koster A; Spannagl M; Giersiefen H; van de Locht A
    Anesthesiology; 2009 Jan; 110(1):123-30. PubMed ID: 19104179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute defibrination hemorrhage caused by stress fibrinolysis during surgery].
    Wille P
    Zentralbl Gynakol; 1968 Aug; 90(35):1177-81. PubMed ID: 5304675
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of proteinases and fibrinolysis inhibitors on experimental brain edema (author's transl)].
    Tzonos T; Rana B
    Z Neurol; 1973 Aug; 205(1):61-70. PubMed ID: 4126738
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of low dose aprotinin on reduction of blood loss after extracorpreal circulation].
    Takahashi K; Hoshino S; Iwaya F; Igari T; Satokawa H; Ono T; Takase S; Ogawa T; Satoh K; Satoh K; Misawa Y; Ishikawa K
    Kyobu Geka; 2000 Dec; 53(13):1085-90. PubMed ID: 11127552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of aminocapronic acid and small-dose trasilol on blood loss after cardiac surgery with extracorporeal circulation].
    Morozov IuA; Charnaia MA; Gladysheva VG
    Anesteziol Reanimatol; 2005; (4):58-60. PubMed ID: 16206590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.